These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29346545)

  • 1. Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers.
    Di Ciano P; Tyndale RF; Mansouri E; Hendershot CS; Wilson AA; Lagzdins D; Houle S; Boileau I; Le Foll B
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):503-512. PubMed ID: 29346545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.
    Dubroff JG; Doot RK; Falcone M; Schnoll RA; Ray R; Tyndale RF; Brody AL; Hou C; Schmitz A; Lerman C
    J Nucl Med; 2015 Nov; 56(11):1724-9. PubMed ID: 26272810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
    Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
    Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of conditioned stimuli on [
    Di Ciano P; de Wit H; Mansouri E; Houle S; Boileau I; Le Foll B
    Sci Rep; 2021 Jun; 11(1):11667. PubMed ID: 34083612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence.
    Liakoni E; Edwards KC; St Helen G; Nardone N; Dempsey DA; Tyndale RF; Benowitz NL
    Clin Pharmacol Ther; 2019 Mar; 105(3):641-651. PubMed ID: 30242831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
    Fehr C; Yakushev I; Hohmann N; Buchholz HG; Landvogt C; Deckers H; Eberhardt A; Kläger M; Smolka MN; Scheurich A; Dielentheis T; Schmidt LG; Rösch F; Bartenstein P; Gründer G; Schreckenberger M
    Am J Psychiatry; 2008 Apr; 165(4):507-14. PubMed ID: 18316420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Nicotine Metabolic Rate on Cigarette Reinforcement.
    Liakoni E; Nardone N; St Helen G; Dempsey DA; Tyndale RF; Benowitz NL
    Nicotine Tob Res; 2020 Jul; 22(8):1419-1423. PubMed ID: 31725872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of smoking-associated cues does not elicit dopamine release after one-hour smoking abstinence: A [11C]-(+)-PHNO PET study.
    Chiuccariello L; Boileau I; Guranda M; Rusjan PM; Wilson AA; Zawertailo L; Houle S; Busto U; Le Foll B
    PLoS One; 2013; 8(3):e60382. PubMed ID: 23555962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate.
    Falcone M; Cao W; Bernardo L; Tyndale RF; Loughead J; Lerman C
    Biol Psychiatry; 2016 Aug; 80(3):190-7. PubMed ID: 26805583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence.
    Okita K; Mandelkern MA; London ED
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27634830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
    Gallezot JD; Kloczynski T; Weinzimmer D; Labaree D; Zheng MQ; Lim K; Rabiner EA; Ridler K; Pittman B; Huang Y; Carson RE; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2014 Mar; 39(4):866-74. PubMed ID: 24220025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans.
    Le Foll B; Guranda M; Wilson AA; Houle S; Rusjan PM; Wing VC; Zawertailo L; Busto U; Selby P; Brody AL; George TP; Boileau I
    Neuropsychopharmacology; 2014 Jan; 39(2):415-24. PubMed ID: 23954846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine Patch Alters Patterns of Cigarette Smoking-Induced Dopamine Release: Patterns Relate to Biomarkers Associated With Treatment Response.
    Zakiniaeiz Y; Liu H; Gao H; Najafzadeh S; Ropchan J; Nabulsi N; Huang Y; Matuskey D; Chen MK; Cosgrove KP; Morris ED
    Nicotine Tob Res; 2022 Oct; 24(10):1597-1606. PubMed ID: 35100429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers.
    Rubinstein ML; Benowitz NL; Auerback GM; Moscicki AB
    Pediatrics; 2008 Sep; 122(3):e643-7. PubMed ID: 18762498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCT.
    Wells QS; Freiberg MS; Greevy RA; Tyndale RF; Kundu S; Duncan MS; King S; Abney L; Scoville E; Beaulieu DB; Gatskie V; Tindle HA
    Nicotine Tob Res; 2018 Nov; 20(12):1489-1496. PubMed ID: 29059367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
    Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [
    Thiruchselvam T; Wilson AA; Boileau I; Le Foll B
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1112-1119. PubMed ID: 28421623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.